Almirall returns InDex's ulcerative colitis drug
Almirall has returned ulcerative colitis therapy Kappaproct to its originator company InDex Pharmaceuticals.
Almirall has returned ulcerative colitis therapy Kappaproct to its originator company InDex Pharmaceuticals.